Programs and funding opportunities

Bridging the Commercialization Gap

IPDC Logo

A common bottleneck to the commercialization of innovative technologies is the scarcity of funding to support early stage applied research and development. This gap between traditional public granting agencies and private investors is often referred to as the “valley of death”.

OICR has an opportunity to make a lasting impact by strategically investing in the very best technologies arising from Ontario’s outstanding research base. OICR’s Intellectual Property Development and Commercialization Fund (the “Fund”) has been designed to address this Valley of Opportunity.

Our vision for the Fund is the creation of a model of commercialization that is founded on collaborative working relationships among institutions, investigators, commercial partners and investors. At the heart of our model is a commercialization team established for each approved project.

The primary purpose of the commercialization team will be to provide expert guidance and oversight to the commercial development of the project. The team will be multi-disciplinary and include representation from the institution or company, inventors and OICR and its business advisors.

Funding is intended to support cancer-related early-stage commercialization activities including: proof-of-concept, validation, standard operating procedures, market analyses, IP protection and acquisition, expert guidance and management.

In addition, it is the objective of OICR to encourage the maximum participation of Ontario organizations in the development, commercialization and utilization of inventions arising from OICR activities – OICR’s “Ontario First Policy.”